Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eradicating Barrett's Esophagus Using Radiofrequency Ablation or a Novel Hybrid Argon Plasma Coagulation Technique (BURN)

NCT03621319 is registered in ClinicalTrials.gov with Erbe Elektromedizin GmbH as lead sponsor.

NCT NCT03621319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03621319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eradicating Barrett's Esophagus Using Radiofrequency Ablation or a Novel Hybrid Argon Plasma Coagulation Technique (BURN)
Lead sponsor
Erbe Elektromedizin GmbH
Phase
Not applicable
Overall status
Terminated
Start date
July 24, 2019
Completion date
May 5, 2021
Enrollment
41 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

barrett's esophagus, high-grade dysplasia in barrett esophagus, low grade dysplasia in barrett esophagus